ArticleWorld journal of cardiology2009
Cardiovascular disease: A global problem extending into the developing world.
Article in World journal of cardiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients.Molecular and cellular biochemistry · 2025Trial
- Arrhythmia Detection by Data Fusion of ECG Scalograms and Phasograms.Sensors (Basel, Switzerland) · 2024Article
- Optimization of the MACE endpoint composition to increase power in studies of lipid-lowering therapies-a model-based meta-analysis.Frontiers in cardiovascular medicine · 2023Review
- Effectiveness of SMART heart package on knowledge and practice regarding prevention of coronary artery disease among high-risk adults in selected urban community at Bangalore.Journal of education and health promotion · 2023Article
- Effect of Phenolic Compounds fromMolecules (Basel, Switzerland) · 2022Article
- Misuse of Cardiac Lipid upon Exposure to Toxic Trace Elements-A Focused Review.Molecules (Basel, Switzerland) · 2022Review
- Uric acid and metabolic syndrome: Findings from national health and nutrition examination survey.Frontiers in medicine · 2022Article
- Identifying a role for the interaction of homocysteine and copper in promoting cardiovascular-related damage.Amino acids · 2021Article
- Ideal Cardiovascular Health Index and Its Determinants in a Rural South African Population.Global heart · 2020Article
- Blood multiomics reveal insights into population clusters with low prevalence of diabetes, dyslipidemia and hypertension.PloS one · 2020Article
- Comparative quantitative systems pharmacology modeling of anti-PCSK9 therapeutic modalities in hypercholesterolemia.Journal of lipid research · 2019Article
- Engaging Community Leaders in the Development of a Cardiovascular Health Behavior Survey Using Focus Group-Based Cognitive Interviewing.Health services insights · 2017Article
- A Case of Severe Carotid Stenosis in a Patient with Familial Hypercholesterolemia without Significant Coronary Artery Disease.Case reports in cardiology · 2014Article
- Therapeutic Potential of Moringa oleifera Leaves in Chronic Hyperglycemia and Dyslipidemia: A Review.Frontiers in pharmacology · 2012Article
- The importance of diabetes mellitus in the global epidemic of cardiovascular disease: the case of the state of Qatar.Transactions of the American Clinical and Climatological Association · 2012Article
- The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism.Current pharmaceutical design · 2012Review
- Current status of stroke in Qatar: Including data from the BRAINS study.JRSM cardiovascular diseaseReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
This article reviews the current status of cardiovascular disease (CVD) on the international scale. Presently viewed as an epidemic that has migrated from westernized societies to developing countries, several important issues are elaborated upon. They include the basis for the increasing prevalence of CVD and the associated societal implications. The challenges related to lack of resources and infrastructure support may also impede successful implementation of proven strategies to reduce CVD. In addition to traditional risk factors such as cigarette smoking, hypertension, obesity, hyperlipidemia, diabetes mellitus and insulin resistance, many developing countries must also contend with other risk biomarkers. Included in this grouping are human immunodeficiency virus/acquired immunodeficiency syndrome and other infectious/inflammatory processes as well as nutritional and vitamin deficiencies that make preventive measures more difficult to prioritize. Taken together, greater partnering between local governments, affiliated hospitals and international societies is needed to enhance and facilitate efforts aimed at optimizing standard of care measures in developing countries in order to reduce cardiovascular risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.